Breaking News Instant updates and real-time market news.

OSTK

Overstock.com

$15.50

(0.00%)

09:13
04/18/19
04/18
09:13
04/18/19
09:13

Overstock.com releases statement on tZERO equity transactions with GSR, Makara

Overstock.com has released the following statement from company CEO and founder and tZERO executive chairman Patrick Byrne on the progress of the previously-announced equity investment from GSR Capital and Makara Capital: "I write to update you on tZERO's negotiations with Makara and GSR Capital on the previously-announced equity investment in tZERO. Makara's due diligence has progressed, and in the course of its due diligence Makara has proven to be a professional and serious fund. Still, the parties will not have a definitive deal in place by the mid-April target. tZERO plans to continue facilitating Makara's diligence, but is not under any exclusivity with Makara or GSR and has retained advisors to pursue parallel alternatives. We will update shareholders after tZERO signs definitive documents. I remind shareholders of the $30 million binding tZERO security token purchase agreement between Overstock and GSR, explained in detail in our Q2 2018 10-Q filing. Under that agreement, GSR has a binding $30 million funding obligation for May 6. Overstock's annual shareholder meeting will occur on May 9: I look forward to reporting to shareholders about the completion of GSR's token purchase on that date. Our retail firm is recovering more dramatically than I anticipated and discussed during our Q4 2018 earnings call. In addition, tZERO is on track to introduce the products described in that phone call. Our intense focus on execution is paying off."

  • 09

    May

OSTK Overstock.com
$15.50

(0.00%)

02/12/19
DADA
02/12/19
NO CHANGE
Target $60
DADA
Underperform
DA Davidson reiterates $60 target on Wayfair citing Amazon 'encroachment'
In a research earlier today titled "Encroachment Is a 5-Yard Penalty," DA Davidson analyst Tom Forte reiterated an Underperform rating on Wayfair with a $60 12-18 month price target. The stock in morning trading is up 1% to $120.89. Amazon.com (AMZN) announced yesterday that it was launching two private-label furniture brands in the U.K., Forte wrote to investors. The analyst sees the news as "yet another indication" of Amazon's intent to expand its efforts in the home category, including furniture. Yesterday's announcement follows Amazon's decision last December to lower third-party selling fees for the furniture category, the analyst points out. Forte views Amazon's efforts to ramp its sales in the home category as an increasing threat for Wayfair. Further, the analyst is monitoring the potential sale of Overstock's (OSTK) legacy home e-commerce business, as he thinks a sale to a large bricks and mortar retailer could also result in additional competition for Wayfair.
03/13/19
DADA
03/13/19
NO CHANGE
Target $58
DADA
Buy
Overstock.com 'compelling' on mispriced assets, says DA Davidson
DA Davidson analyst Tom Forte kept his Buy rating and $58 price target on Overstock.com, maintaining his view that the stock is "compelling" with e-commerce and blockchain assets as mis-priced. The analyst estimates $31 per share valuation in e-commerce "unlocked through sale to a strategic buyer" and $27 per share for the company's Medici ventures blockchain portfolio. Ahead of next week's earnings call, Forte forecasts Overstock.com to post a 6% revenue growth. The analyst adds that he is looking forward to the company allowing all investors, not just accredited ones to trade its tZERO security tokens.
03/19/19
DADA
03/19/19
NO CHANGE
Target $51
DADA
Buy
Overstock.com price target lowered to $51 from $58 at DA Davidson
DA Davidson analyst Tom Forte lowered his price target on Overstock.com to $51 after its Q4 earnings miss, modeling all of the reduction to its legacy e-commerce business while maintaining the valuation on its Medici Ventures business at $25 per share. The analyst also keeps his Buy rating on the company, noting the progress and plans for tZERO provide "ample reason" that the share price "does not properly reflect the value of its portfolio". Forte maintains his positive stance related to Medici's completed first cryptobond offering, completed first crypto stocking, and being "one of the first to complete a securitized token offering and to launch an alternative trading system."
03/20/19
DADA
03/20/19
NO CHANGE
Target $51
DADA
Buy
Overstock.com 10K filing anticipates Q1 revenue decline, says DA Davidson
DA Davidson analyst Tom Forte kept his Buy rating and $51 price target on Overstock.com after its 10-K filing release, which anticipates Q1 revenue to decline by 17%-19% from last year's levels and implies $361M-$370M vs. $421M consensus. The analyst cites the management's "intention to continue to scale back sales and marketing expenses and increase operating efficiencies" with staff reductions, but also remains positive on its Medici Ventures vision to develop blockchain technology, as highlighted in the company's Q4 earnings call.

TODAY'S FREE FLY STORIES

BIIB

Biogen

$293.92

1.71 (0.59%)

07:33
12/13/19
12/13
07:33
12/13/19
07:33
Hot Stocks
Breaking Hot Stocks news story on Biogen »

Biogen to discontinue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$293.92

1.71 (0.59%)

07:32
12/13/19
12/13
07:32
12/13/19
07:32
Hot Stocks
Biogen: Primary endpoint not statistically significant in Phase 2 PASSPORT study »

Biogen announced topline…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$305.76

2.01 (0.66%)

07:32
12/13/19
12/13
07:32
12/13/19
07:32
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

CG

Carlyle Group

$29.83

-0.36 (-1.19%)

07:31
12/13/19
12/13
07:31
12/13/19
07:31
Hot Stocks
Funds advised by Apax Partners to acquire Coalfire from Carlyle Group, Chertoff »

Funds advised by Apax…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

ADBE

Adobe

$305.76

2.01 (0.66%)

07:30
12/13/19
12/13
07:30
12/13/19
07:30
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

SAFM

Sanderson Farms

$166.66

2.5 (1.52%)

07:30
12/13/19
12/13
07:30
12/13/19
07:30
Initiation
Sanderson Farms initiated  »

Sanderson Farms initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

ORCL

Oracle

$56.47

0.16 (0.28%)

07:30
12/13/19
12/13
07:30
12/13/19
07:30
Recommendations
Oracle analyst commentary  »

Oracle shares to come…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVGO

Broadcom

$327.39

7.53 (2.35%)

07:28
12/13/19
12/13
07:28
12/13/19
07:28
Recommendations
Broadcom analyst commentary  »

Broadcom price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCLH

Norwegian Cruise Line

$56.12

0.72 (1.30%)

07:27
12/13/19
12/13
07:27
12/13/19
07:27
Recommendations
Norwegian Cruise Line analyst commentary  »

Norwegian Cruise Line…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$305.76

2.01 (0.66%)

07:26
12/13/19
12/13
07:26
12/13/19
07:26
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

ADBE

Adobe

$305.76

2.01 (0.66%)

07:25
12/13/19
12/13
07:25
12/13/19
07:25
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

DCP

DCP Midstream

$23.70

-0.56 (-2.31%)

07:25
12/13/19
12/13
07:25
12/13/19
07:25
Initiation
DCP Midstream initiated  »

DCP Midstream initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jan

07:25
12/13/19
12/13
07:25
12/13/19
07:25
Conference/Events
UBS analyst manley to hold an analyst/industry conference call »

Analyst Manley discusses…

TDOC

Teladoc

$77.06

-0.36 (-0.46%)

07:24
12/13/19
12/13
07:24
12/13/19
07:24
Initiation
Teladoc initiated  »

Teladoc initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIMT

Aimmune

$31.60

0.78 (2.53%)

07:22
12/13/19
12/13
07:22
12/13/19
07:22
Downgrade
Credit Suisse downgrades Aimmune with peanut allergy approval widely expected »

Credit Suisse analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDSN

Nordson

$162.94

-4.5 (-2.69%)

07:22
12/13/19
12/13
07:22
12/13/19
07:22
Downgrade
Nordson rating change  »

Nordson downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLUE

Bluebird Bio

$84.00

-2.97 (-3.42%)

07:20
12/13/19
12/13
07:20
12/13/19
07:20
Upgrade
Bluebird Bio rating change  »

Bluebird Bio upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

07:19
12/13/19
12/13
07:19
12/13/19
07:19
Upgrade
Bristol-Myers rating change  »

Bristol-Myers upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BNS

Bank of Nova Scotia

$56.73

0.145 (0.26%)

07:19
12/13/19
12/13
07:19
12/13/19
07:19
Downgrade
Bank of Nova Scotia rating change  »

Bank of Nova Scotia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

SKX

Skechers

$41.65

0.89 (2.18%)

07:18
12/13/19
12/13
07:18
12/13/19
07:18
Upgrade
Skechers rating change  »

Skechers upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETSY

Etsy

$41.97

0.95 (2.32%)

07:17
12/13/19
12/13
07:17
12/13/19
07:17
Initiation
Etsy initiated  »

Etsy initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$100.39

-1.15 (-1.13%)

07:16
12/13/19
12/13
07:16
12/13/19
07:16
Recommendations
Sarepta price target raised to $260 from $160 at H.C. Wainwright »

H.C. Wainwright analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$119.76

0.72 (0.60%)

07:15
12/13/19
12/13
07:15
12/13/19
07:15
Periodicals
Bonobos founder Andy Dunn leaving Walmart in 2020, CNBC reports »

Andy Dunn, the founder of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGNE

BeiGene

$179.27

-0.33 (-0.18%)

, MRTX

Mirati Therapeutics

$106.24

0.39 (0.37%)

07:14
12/13/19
12/13
07:14
12/13/19
07:14
Hot Stocks
BeiGene announces clinical data on tislelizumab in combination with sitravatinib »

BeiGene (BGNE) and Mirati…

BGNE

BeiGene

$179.27

-0.33 (-0.18%)

MRTX

Mirati Therapeutics

$106.24

0.39 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

ADBE

Adobe

$305.76

2.01 (0.66%)

07:13
12/13/19
12/13
07:13
12/13/19
07:13
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.